CSIMarket


Karuna Therapeutics Inc   (KRTX)
Other Ticker:  
 


 

Karuna Therapeutics Inc

KRTX's Financial Statements and Analysis



Karuna Therapeutics Inc increased third quarter of 2023 net loss per share of $-3.16 compare to net loss per share of $-2.38 recorded in the same quarter a year ago a decrease compare to $-2.75 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -3.16 $  0 Mill
$-0.78     Unch.    



Karuna Therapeutics Inc 's Revenue fell by 0 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by sequentially.


Karuna Therapeutics Inc is

More on KRTX's Income Statement



Karuna Therapeutics Inc 's in thethird quarter of 2023 recorded net loss of $-119.119 million, an increase from net loss of $-76.963 million in III. Quarter a year ago.

Sequentially net loss advanced

More on KRTX's Growth

Karuna Therapeutics Inc Inventories
In Sep 30 2023 company's net cash and cash equivalents decreased by $-49 million, capital expenditures fell by -0.174261.49%, to $-1 millions compare to same quarter a year ago

More on KRTX's Cash flow Statement


Karuna Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Karuna Therapeutics Inc payed $ -9.38 cash per share, on a free-cash flow basis .

Book value fell by -7.26 % sequentially to $35.08 per share, -25.52% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 35.08 per share from $ 37.83.

Company issued 0.16 million shares or 0.44 % in Sep 30 2023.


More on KRTX's Dividends

 Market Capitalization (Millions) 12,431
 Shares Outstanding (Millions) 38
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -396
 Cash Flow (TTM) (Millions $) -23
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 10




Karuna Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Karuna Therapeutics Inc had negative $ -9.38 cash flow per share, on a free-cash flow basis .

Book value fell by -7.26 % sequentially to $35.08 per share, -25.52% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 35.08 per share from $ 37.83.

Company issued 0.16 million shares or 0.44 % in Sep 30 2023.


More on KRTX's Balance Sheets

 Market Capitalization (Millions) 12,431
 Shares Outstanding (Millions) 38
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -396
 Cash Flow (TTM) (Millions $) -23
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 10
   


  News about Karuna Therapeutics Inc Earnings

Karuna Therapeutics Inc.'s Q3 2023 Financial Results Show Consistent Revenue Growth Compared to Previous Year



Karuna Therapeutics, Inc. has recently released its financial results fo...

Karuna Therapeutics Inc Shows Similar Revenue to Previous Year in Q2 2023 Despite Extended Losses

The...

Karuna Therapeutics Inc Struggles Financially with a Net Loss of $316 Million, Raising Concerns Over Shareholders' Investments

Karuna Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing innovative therapies for treating neuropsychiatric disorders, has been facing some financial challenges as revealed by its recent financial report. The company recorded a cumulative net loss of $-316 million during 12 months ending in the first quarter of 2023, resulting in a negative return on equity (ROE) of -30.04%.
The negative ROE is a cause for concern as it indicates that Karuna Therapeutics Inc is not generating sufficient profits from shareholders' investments.
Within the Major Pharmaceutical Preparations industry, 36 other companies ...


Date modified: 2023-11-03T16:39:24+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com